Approaches to improve epidemiological studies of diabetic neuropathy: Insights from the Rochester Diabetic Neuropathy Study

Diabetes

Volumn 46, Issue SUPPL. 2, 1997, Pages

  Dyck, Peter J ^a   Melton III, L Joseph ^a   O'Brien, Peter C ^a   Service, F John ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CONFERENCE PAPER; DIABETES CONTROL; DIABETIC NEUROPATHY; DISEASE SEVERITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030967758     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.s5     Document Type: Conference Paper

References (28)

1. Thomas PK, Tomlinson DR: Diabetic and hypoglycemic neuropathy. In Peripheral Neuropathy. Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, Eds. Philadelphia, Saunders, 1993, p. 1219-1250
2. DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35:530-545, 1986
3. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
4. DCCT Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122:561-568, 1995
5. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, Palumbo PJ, Swanson CJ: Human diabetic endoneurial sorbital, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 8:590-596, 1980
6. Dyck PJ, Karnes J, O'Brien PC, Swanson CJ: Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 36:1300-1308, 1986
7. Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O'Brien PC, Service FJ: Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 10:432-440, 1987
8. Melton LJ III, Palumbo PJ, Chu CP: Incidence of diabetes mellitus by clinical type. Diabetes Care 6:75-86, 1983
9. Melton LJ, Ochi JW, Palumbo PJ, Chu C-P: Sources of disparity in the spectrum of diabetes mellitus at incidence and prevalence. Diabetes 6:427-431, 1983
10. Melton LJ, Dyck PJ: Section III: epidemiology. In Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury A, Winegrad A, Porte D, Eds. Philadelphia, Saunders, 1987, p. 27-35
11. O'Brien PC, Dyck PJ: Procedures for setting normal values. Neurology 45:17-23, 1995
12. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC: Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects (RDNS-HS). Neurology 45:1115-1121, 1995
13. Pirart J: Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1:168-188, 1978
14. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton LJ III, Service FJ: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993
15. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ III, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA, Service FJ, Rizza RA, Zimmerman BR: The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 41:799-807, 1991
16. Melton LJ, Dyck PJ, Karnes JL, O'Brien PC, Service FJ: Non-response bias in studies of diabetic complications: the Rochester Diabetic Neuropathy Study. J Clin Epidemiol 4:341-318, 1993
17. Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ: Clinical and neuropathological criteria for the diagnosis and staging of diabetic neuropathy. Brain 108:861-880, 1985
18. San Antonio Conference: Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Neurology 42:1823-1839, 1992
19. Pirart J: Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Part 2. Diabetes Care 1:252-263, 1978
20. Gregersen G: Diabetic neuropathy: influence of age, sex metabolic control, and duration of diabetes on motor conduction velocity. Neurology 17:972-980, 1967
21. Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsigos C, Young RJ, Ward JD, Boulton AJ: The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabetic Med 11:480-484, 1994
22. O'Hare JA, Abuaisha F, Geoghegan M: Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir Med J 163:132-135, 1994
23. Harris M, Eastman R, Cowie C: Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 16:1446-1452, 1993
24. Palumbo PJ, Elveback LR, Whisnant JP: Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol 19:593-602, 1978
25. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF: Risk factors for distal symmetric neuropathy in NIDDM: the San Luis Valley Diabetes Study. Diabetes Care 17:1172-1177, 1994
26. LaPorte RE, Tajima N, Dorman JS, Cruickshanks KJ, Eberhardt MS, Rabin BS, Atchison RW, Wagener DK, Becker DJ, Orchard TJ, Songer TJ, Slemenda CW, Kuller LH, Drash AL: Differences between blacks and whites in the epidemiology of insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania. Am J Epidemiol 123:592-603, 1986
27. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Ellis D, LaPorte RE, Kuller LH, Wolfson SK Jr, Drash AL: Factors associated with avoidance of severe complications after 25 years of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 13:741-747, 1990
28. Walters DR Gatling W, Mullee MA, Hill RD: The prevalence of diabetic distal sensory neuropathy in an English community. Diabetic Med 9:349-353, 1992